elacridar
E2046106
UNEXPLORED
Elacridar is a potent third-generation inhibitor of the P-glycoprotein (ABCB1) and breast cancer resistance protein (BCRP) efflux transporters, used experimentally to enhance drug penetration across biological barriers such as the blood–brain barrier.
All labels observed (1)
| Label | Occurrences |
|---|---|
| elacridar canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.